mTOR is a key pathway that regulates fundamental physiological processes, and could serve as a potential therapeutic target for the development of anti-obesity therapies (65), however, using direct mTOR inhibitors to lower lipogenesis may have adverse effects on homeostasis (66). The gene discussed is MTOR; the disease is obesity due to melanocortin 4 receptor deficiency.